ENDOCYTE Community Page | What other sites are saying about ENDOCYTE

ENDOCYTE

(NQ: ECYT)

14.02 USD UNCHANGED

Official Closing Price / Updated: 8:10 PM EDT, May 24, 2013 / Add to My Watchlist

(ECYT) Community Analysis from

Related Wikinvest articles

May 25, 2013

(MAA) Revenues Rise at Endocyte

(Stock Blog Hub, 2/26/13)

Endocyte, Inc. (ECYT) reported fourth quarter 2012 net loss per share of 2 cents, in line with the Zacks Consensus Estimate and narrower than the year-ago loss of 30 cents. Fourth quarter...(read more)

Merck & Co. Inc. Signs Cancer Drug Deal

(eMoneyDaily, 4/17/12)

Merck & Co. Inc. (NYSE:MRK) has signed a deal with Endocyte to develop and commercialize the cancer drug vintafolide.

View all posts about Endocyte (ECYT)

Endocyte (ECYT) Company Overview

There is no analysis for ECYT yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates